Assessing the Bioavailability of Leading Phytonutrient Products

Not Applicable

• Conditions: Inflammation
• Interventions: Dietary Supplement: Curcumin

• Registration Number: NCT05349032
• Lead Sponsor: Epiceutical Labs

Brief Summary

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. The study will secondarily look at inflammatory markers in the urine to determine any change.

Detailed Description

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. 120 mg of curcumin from brands Meriva, CurcElite, Lonvida, UltraCur, NovaSol. The study will secondarily look at inflammatory markers in the urine to determine any change.

Study Timeline

• Study Start: 2022-03-01
• Status Verified: 2022-04
• Study First Submitted: 2022-04-21
• Study First Submitted QC: 2022-04-21
• Last Update Submitted: 2022-04-21
• Study First Posted: 2022-04-27
• Last Update Posted: 2022-04-27
• Primary Completion: 2022-04-30
• Study Completion: 2022-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 15

Inclusion Criteria

• Age and gender

Exclusion Criteria

• Cannot take any phytonutrient or curcumin supplement five days prior to commencement.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Meriva	Curcumin	120 mg of curcumin in Meriva.
Longvida	Curcumin	120 mg of curcumin Longvida.
NovaSol	Curcumin	120 mg of curcumin NovaSol
UltaCur	Curcumin	120 mg of curcumin Ultracur
CurcElite	Curcumin	120 mg of curcumin CurcElite

Primary Outcome Measures

Name	Time	Method
Bioavailability	0, 1, 2, 4, and 12 hours	Blood Plasma

Trial Locations

Locations (1)

David Roberts; 🇺🇸 Charlottesville, Virginia, United States